LIEN

Business Context and Reporting Period

Company: Silver Spike Investment Corp. (SSIC) (Note: Request metadata listed "Chicago Atlantic BDC, Inc." but the filing text is for Silver Spike Investment Corp.)
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2022
Business Overview: SSIC is an externally managed, closed-end, non-diversified Business Development Company (BDC) and Regulated Investment Company (RIC). It focuses on investing in the cannabis ecosystem through direct loans and equity ownership of privately held cannabis companies. The company commenced operations on February 8, 2022, following an IPO that raised approximately $83.3 million in net proceeds. As of the reporting date, the company had not yet closed on a portfolio investment, though it funded a $21 million debt investment to Shryne Group, Inc. on May 27, 2022 (subsequent event).

Key Financial Metrics

Note: The company reported no debt outstanding as of March 31, 2022. Expenses were primarily driven by organizational and offering costs associated with the IPO.

Material Changes vs. Prior Period

• Capitalization: The company transitioned from a pre-operational shell with no assets to a fully capitalized entity following its February 2022 IPO. Net assets increased from a deficit of $159,715 to $84.55 million.
• Operations: The company commenced operations in February 2022. While it generated minimal interest income ($10,073) from temporary cash investments, it incurred significant organizational expenses ($328,002) and offering costs.
• Investment Portfolio: As of March 31, 2022, the company held no portfolio investments. The first investment ($21 million) was funded in May 2022, subsequent to the reporting period.
• Stock Performance: Common stock began trading on February 4, 2022. As of June 27, 2022, the stock traded at a discount of approximately 32.8% to its NAV.

Guidance, Outlook, Risks, and Unusual Items

Outlook and Strategy

SSIC intends to invest primarily in secured and unsecured debt, equity warrants, and direct equity in private leveraged middle-market cannabis companies. The company targets a debt-to-equity ratio of 0.50x. Management expects to generate current income from debt investments and capital appreciation from equity. The company has an active pipeline of over $1.25 billion in potential investments.

Management Commentary

Management highlighted the nascent status of the cannabis industry and the lack of traditional bank lending to this sector as a key opportunity. They noted that while the industry is growing, it faces significant regulatory and legal risks due to the conflict between state legalization and federal prohibition.

Risks and Contingencies

• Regulatory Risk: Cannabis remains illegal under U.S. federal law. Strict enforcement could result in the inability of portfolio companies to execute business plans or the forfeiture of assets.
• Liquidity Risk: Investments in private companies are illiquid. The company may be unable to sell investments quickly or at fair value.
• Internal Control Weakness: The company identified a material weakness in internal controls over financial reporting regarding the classification of offering and organizational expenses in the prior period. This has been corrected in the current filing.
• Concentration Risk: The Seed Investor (Silver Spike Capital, LLC) holds approximately 72% of voting stock, giving it substantial control over corporate actions.

Unusual Items

The company incurred significant one-time offering and organizational costs during the period, which resulted in a net loss despite the influx of capital. No distributions were paid during the fiscal year.

Key Facts for Investor Verification

• First Investment Timing: Verify the performance and terms of the first portfolio investment (Shryne Group, Inc., $21 million) funded in May 2022, as the company had no operating portfolio at the reporting date.
• Stock Discount: Monitor the trading price relative to NAV, as the stock was trading at a significant discount (~33%) shortly after the IPO, which may impact future capital raising ability.
• Internal Control Remediation: Confirm that the material weakness regarding expense classification has been fully remediated and that no further misstatements have occurred.
• Regulatory Environment: Assess the impact of potential changes in U.S. federal cannabis policy (e.g., rescheduling, SAFE Banking Act) on the company's investment thesis and portfolio company viability.
• Expense Structure: Review the transition from one-time offering costs to recurring operating expenses (management fees, administrative costs) as the company becomes fully invested.